The Oral Syringes market is expected to grow at a CAGR of 6.72% to reach USD 1,177.99 million in 2027.
.jpg "The Global Oral Syringes Market 2022-2032 (USD Million)")
The demand for prefilled syringes is growing due to the increasing pediatric population, the ease of use and the increasing prevalence of chronic diseases in the geriatric population. The rising number of surgical procedures in the pediatric and geriatric population worldwide are certain factors that are propelling the growth of the global oral syringes market.
Oral syringes are used to inject oral medicine directly into the patient's mouth. They are designed to reduce the risk of drug dosing, thus curbing the chances of administrative error. Oral syringes can meet the needs of patients of all age groups, and these syringes can be used many times over a span of seven days by an individual patient. Medical needle syringes are the parent market for oral syringes and some potential associated markets for oral syringes include injection pens, specialty needles and insulin pumps. Over the years, the industry has progressed from the use of dosing cups, droppers and the use of teaspoons to the use of oral syringes when taking liquid medicine to improve the probability of giving proper doses.
Furthermore, since the prevalence of acute diseases caused by excessive dosage consumption is rising, the need for accurate medication consumption has increased, contributing to the growth of the worldwide market for oral syringes. Oral syringes are simple to use and can be pre-sterilized so that they can be re-used and help to reduce the loss of drugs as well. Together, all these variables drive the global demand for oral syringes. In addition, the increase in the prevalence of cancer in the pediatric and geriatric population has also flourished the demand for disposable oral syringes. As the disposable oral syringes are mostly used with chemotherapy. Hence, these factors are anticipated to grow the demand of oral syringes during the forecast period.
Key players operating in the global oral syringes market include Becton, Dickinson and Company, Braun Melsungen AG, Medtronic, Amcor Limited, Smiths Medical, NIPRO Corporation, Gerresheimer AG, and Terumo Corporation, among others.
Oral Syringes Market Scope
| Metrics | Details |
| Base Year | 2022 |
| Historic Data | 2017-2018 |
| Forecast Period | 2022-2027 |
| Study Period | 2017-2027 |
| Forecast Unit | Value (USD) |
| Revenue forecast in 2027 | USD 1,177.99 million |
| Growth Rate | CAGR of 6.72% during 2017-2027 |
| Segment Covered | By Product, By Usage, By End-user, Regions |
| Regions Covered | North America, Europe, Asia Pacific, Middle East and Africa, South America |
| Key Players Profiled | 3M Company, AdvaCare Pharma, Becton, Dickinson, and Company, Braun Melsungen AG, Cadence Science, Inc., Cardinal Health, Inc., Cotran Corp., Gerresheimer AG, Hindustan Syringes & Medical Devices, Ltd., Medline Industries, Inc., Medtronic, PLC, NeoMed, Inc., Smiths Medical, Inc., Terumo Corp, The Medi-Dose Group, Vitality Medical, Inc |
Key Segments of the Global Oral Syringes Market
Product Type Overview (USD Million)
- Colorful Oral Syringes
- Clear Oral Syringes
Usage Overview (USD Million)
- Disposable Oral Syringes
- Reusable Oral Syringes
End-Users Overview (USD Million)
- Hospitals
- Homecare Settings
- Clinics
Regional Overview (USD Million)
- North America
- U.S.
- Canada
- Europe
- Germany
- United Kingdom
- France
- Rest of Europe
- Asia Pacific
- China
- Japan
- India
- Rest of Asia Pacific
- Latin America
- Brazil
- Mexico
- Rest of Latin America
- Middle East & Africa
Reasons for the study
- Rising number of surgical procedures in the pediatric and geriatric population
- Rising pediatric population, easy usability, and increasing prevalence of chronic diseases in the geriatric population
What does the report include?
- The study on the global oral syringes market includes qualitative insights such as drivers, restraints, challenges and opportunities
- Additionally, the market has been evaluated using the Porter’s five forces analysis
- The study covers qualitative and quantitative analysis of the market segmented on the basis of product type and end-users. Moreover, the study on oral syringes market provides similar information for the key geographies.
- Actual market sizes and forecasts have been provided for all the above-mentioned segments
- The study includes the profiles of key players operating in the market with a significant global and/or regional presence
Who should buy this report?
- The report on the global oral syringes market is suitable for all the players across the value chain including raw medical material suppliers, hospitals, long-term care facilities, neurosurgeons’ clinics, homecare settings, medical device manufacturers, healthcare organizations, distributors, suppliers and wound type geeks
- Venture capitalists and investors looking for more information on the future outlook of the global oral syringes market
- Consultants, analysts, researchers, and academicians looking for insights shaping the global oral syringes market
Frequently Asked Questions (FAQ) :
oral syringes market was valued at USD 628.9 million in 2019.
North America dominated the market for oral syringes market and accounted for the largest revenue share
The major contenders in the global oral syringes market Becton, Dickinson and Company, Braun Melsungen AG, Medtronic, Amcor Limited, Smiths Medical, NIPRO Corporation, Gerresheimer AG, and Terumo Corporation, among others.
The need for oral syringes has significantly increased owing to the increasing number of medication errors in the pediatric population. According to a report in the U.S., About 200,000 prescription errors are recorded annually to the U.S. poison control centres by pharmacists in 2019, and around 30.0% of cases are linked to children. Moreover, rising prevalence of cancer globally is also a driver for oral syringes market. As disposable oral syringes are mostly used with chemotherapy for cancer. According to the World Cancer Research Fund International data report 2018, around 296,851 new cases of brain and central nervous system cancer were diagnosed globally in 2018. The world 's high prevalence of cancer puts a high economic burden on countries. Therefore, it anticipates the growth of oral syringes market.
Furthermore, children's medicines are mostly liquid, unlike most adult drugs, and the administration of liquid medicine by cups and spoons leads to severe errors. Most healthcare organizations encourage the use of oral syringes worldwide in order to minimize the occurrence of drug errors in infants. For example, in order to raise awareness of oral syringes in Spain, the Institute for Safe Use of Medications (ISMP) publishes periodic newsletters and educational programs. In addition, in order to improve key companies’ portfolio in the market, key companies are also developing technologically advanced oral syringes. For instance, in order to retain market share in the industry, BD has improved its product line. These factors likely to boost the demand for oral syringes during the forecast period.
The global oral syringes market has been segmented based on product type, usage, end-users and region. Based on product type, the oral syringes market is segmented into colorful oral syringes, and clear oral syringes wherein the clear oral syringes segment dominated the market in 2019. Clear syringes aids to better viewing of medication and graduation markings.
On the basis of usage, the oral syringes market is segmented into disposable oral syringes, and reusable oral syringes. The reusable oral syringes segment dominated the market due to the lack of risk of infections and any transfer of dangerous diseases due to oral route administration. The disposable oral syringes segment is projected to see the highest growth rate during the forecast period due to the rise in the prevalence of cancer in the pediatric and geriatric population. For chemotherapy, disposable oral syringes are mostly used.
Based on end-users, the oral syringes market is segmented into hospitals, homecare settings, and clinics. The hospital segment dominated the market due to the growing worldwide hospitalization rate. In addition, high recognition among doctors and nursing staff in hospital settings leads to the segment's greater market share.
The global oral syringes market is cumulative to North America, Europe, Asia Pacific, Latin America and Middle East & Africa. North America dominated the global oral syringes market in 2019, however Asia Pacific is expected to grow at a highest pace through 2028.
North America, especially the U.S. dominates the global oral syringes market. This is due to the existence of well-established healthcare facilities in the area, growing prevalence of cancers and chronic diseases. Furthermore, the involvement of the region's major players has led to market development. The region's prominent players include BD, Cardinal Fitness, and B. AG Braun Melsungen.
Asia Pacific is expected to be the fastest growing regional market for oral syringes owing to factors such as the existence of a large patient base, growing medical tourism, and rising healthcare spending by the government. In addition, increasing the pediatric and geriatric population is anticipated to increase the demand for oral syringes in the region.